Surgical Innovations Group (LSE:SUN) Cash-to-Debt : 0.73 (As of Dec. 2023)

View and export this data going back to 1988. Start your Free Trial

What is Surgical Innovations Group Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Surgical Innovations Group's cash to debt ratio for the quarter that ended in Dec. 2023 was 0.73.

If Cash to Debt ratio is less than 1, the company cannot pay off its debt using the cash in hand. Here we can see, Surgical Innovations Group couldn't pay off its debt using the cash in hand for the quarter that ended in Dec. 2023.

The historical rank and industry rank for Surgical Innovations Group's Cash-to-Debt or its related term are showing as below:

LSE:SUN' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.17 Med: 0.87 Max: 14.62
Current: 0.73

During the past 13 years, Surgical Innovations Group's highest Cash to Debt Ratio was 14.62. The lowest was 0.17. And the median was 0.87.

LSE:SUN's Cash-to-Debt is ranked worse than
67.17% of 862 companies
in the Medical Devices & Instruments industry
Industry Median: 1.935 vs LSE:SUN: 0.73

Surgical Innovations Group Cash-to-Debt Historical Data

The historical data trend for Surgical Innovations Group's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Surgical Innovations Group Cash-to-Debt Chart

Surgical Innovations Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash-to-Debt

Get a 7-Day Free Trial

0.61

1.61

1.31

1.02

0.73

Surgical Innovations Group Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Cash-to-Debt	Get a 7-Day Free Trial															1.31	1.28	1.02	0.72	0.73

Competitive Comparison of Surgical Innovations Group's Cash-to-Debt

For the Medical Devices subindustry, Surgical Innovations Group's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Surgical Innovations Group's Cash-to-Debt Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Surgical Innovations Group's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Surgical Innovations Group's Cash-to-Debt falls into.

Surgical Innovations Group Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Surgical Innovations Group's Cash to Debt Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	1.212	/	(0.611	+	1.051)
	=	0.73

Surgical Innovations Group's Cash to Debt Ratio for the quarter that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	1.212	/	(0.611	+	1.051)
	=	0.73

Surgical Innovations Group (LSE:SUN) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Surgical Innovations Group Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Surgical Innovations Group's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Surgical Innovations Group (LSE:SUN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Surgical Innovations Group PLC (LSE:SUN) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

Clayton Wood House, 6 Clayton Wood Bank, Leeds, GBR, LS16 6QZ

Website

https://www.sigroupplc.com

Surgical Innovations Group PLC is involved in the design, development, manufacture, and sale of devices for use in minimally invasive surgery and precision engineering markets. The group sells branded products through independent healthcare distributors across the world and own-label products through original equipment manufacturer relationships. The SI Brand segment includes research, development, manufacture, and distribution of SI branded minimally invasive devices. The OEM segment includes the research, development, manufacture, and distribution of minimally invasive devices for third-party medical device companies through either own label or co-branding. The distribution segment includes the distribution of specialist medical products.